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The circadian timing system synchronizes cellular
function by coordinating rhythmic transcription via
a transcription-translational feedback loop. How
the circadian system regulates gene expression at
the translational level remains a mystery. Here, we
show that the key circadian transcription factor
BMAL1 associates with the translational machinery
in the cytosol and promotes protein synthesis. The
mTOR-effector kinase, ribosomal S6 protein kinase
1 (S6K1), an important regulator of translation, rhyth-
mically phosphorylates BMAL1 at an evolutionarily
conserved site. S6K1-mediated phosphorylation is
critical for BMAL1 to both associate with the transla-
tional machinery and stimulate protein synthesis.
Protein synthesis rates demonstrate circadian oscil-
lations dependent on BMAL1. Thus, in addition to its
critical role in circadian transcription, BMAL1 is a
translation factor that links circadian timing and the
mTOR signaling pathway. More broadly, these re-
sults expand the role of the circadian clock to the
regulation of protein synthesis.
INTRODUCTION
Circadian timing is a ubiquitous and evolutionarily conserved
property of cells and animal behavior (Bass and Takahashi,
2010; Lowrey and Takahashi, 2011). On a molecular level, tran-
scriptional-translational feedback loops are a common orga-
nizing principle of circadian clocks across kingdoms (Koike
et al., 2012; Ukai and Ueda, 2010). Additionally, epigenetic,
translational, and post-translational mechanisms confer both
robustness and plasticity to the clock (Eckel-Mahan et al.,
2012; Gallego and Virshup, 2007; Lim and Allada, 2013b). In an-
imals, the Per, Arntl, Sim1-(PAS-), and basic helix-loop-helix-
(bHLH)-domain-containing transcription factors brain muscle
aryl nuclear translocase like-1 (BMAL1; ARNTL; CYCLE1;
MOP3) and circadian locomotor output cycles kaput (CLOCK)1138 Cell 161, 1138–1151, May 21, 2015 ª2015 Elsevier Inc.drive transcription of clock-controlled genes (CCGs) (Lowrey
and Takahashi, 2011). BMAL1 is unique among core clock pro-
teins because it is essential for circadian transcription and
behavior (Bunger et al., 2000). BMAL1 cycles between the nu-
cleus and cytosol, but no cytosolic function for BMAL1 has yet
been established (Kwon et al., 2006; Tamaru et al., 2003).
While a majority of molecular circadian research has focused
on transcriptional mechanisms, transcription is not required
for all circadian phenomena. For example, post-translational
rhythmshavebeendemonstrated in enucleatedhuman redblood
cells (O’Neill and Reddy, 2011). In addition, several studies have
demonstrated that the rhythmicity of an mRNA is not necessarily
predictive of the rhythmicity of its cognate protein (Mauvoisin
et al., 2014; Reddy et al., 2006). These reports raise fundamental
questions about whether and how the circadian clock regulates
post-transcriptional gene expression (Lim and Allada, 2013b).
Protein synthesis is a fundamental property of living systems
that—like the circadian clock—is both tightly regulated by and
responsive to dynamic cellular and environmental changes
(Sonenberg andHinnebusch, 2009). Translation is primarily regu-
lated at the initiation step (Aitken andLorsch, 2012).MostmRNAs
have a 7-methyl guanosine (m7-(GpppG)n) ‘‘cap’’ at their 5
0 end.
The cap-binding protein, eukaryotic initiation factor 4E (eIF4E),
binds this mRNA cap and subsequently recruits multi-protein
cap-binding complexes. Cap-dependent translation is promoted
by anabolic stimuli transmitted through the mechanistic target of
rapamycin (mTOR) signaling pathway. mTOR stimulates transla-
tion by phosphorylation of eIF4E-binding proteins (4E-BPs) and
S6K1/2 (Ma and Blenis, 2009). Recent studies have reported
circadian oscillations in mTOR signaling (Cornu et al., 2014;
Jouffe et al., 2013; Khapre et al., 2014); however, little is known
about mechanisms underlying the timing of mTOR-mediated
protein synthesis in relation to the light-dark cycle.
Supporting a connection between the circadian clock and
translational regulation, total mRNA levels for many ribosomal
proteins are not rhythmic on circadian timescales yet their poly-
some-bound fractions are (Jouffe et al., 2013). Moreover, loss of
Bmal1 alters the circadian rhythmicity of ribosomal protein
expression. Interestingly, BMAL1 is structurally and evolution-
arily related to the transcription factor, hypoxia inducible fac-
tor-2a (HIF-2a); HIF-2a biochemically interacts with translation
factors to regulate hypoxia-dependent translation (McIntosh
et al., 2010; Uniacke et al., 2012).
Based on these reports, we hypothesized that BMAL1 regu-
lates post-transcriptional gene expression. We demonstrate
that BMAL1 interacts with the translational machinery in the
cytosol in response to S6K1-mediated phosphorylation.
BMAL1 stimulates translation in cells in a manner independent
of its role as a transcription factor. S6K1-mediated phosphoryla-
tion places BMAL1 in context of the mTOR pathway, a major
cellular regulator of translation. In synchronized cells, protein
synthesis rates demonstrate circadian oscillations that are
partially BMAL1-dependent. Together, our data demonstrate
that BMAL1 is a translation factor that links mTOR-mediated
translation to the circadian clock.RESULTS
BMAL1 Interacts with Translational Regulators in the
Cytosol
We reasoned that if BMAL1 has a role in post-transcriptional
gene expression, characterization of its cytosolic binding
partners would yield insights into this potential function. We
performed immunoprecipitations of endogenous BMAL1 from
cytosolic fractions of immortalized wild-type (WT) mouse embry-
onic fibroblasts (MEFs) (Figures 1A and 1B).We used unsynchro-
nized cells to eliminate a priori assumptions about when during
the circadian cycle BMAL1 might act in the cytosol. We charac-
terized proteins that co-precipitated with BMAL1 by SDS-PAGE
followed bymass spectrometry (MS). We retrieved peptides cor-
responding to 308 annotated mouse proteins (Tables S1A–S1C).
To analyze the putative function of the BMAL1-associated pro-
teins in the cytoplasm, we performed a network clustering anal-
ysis using a Markov Clustering Algorithm with the Search Tool
for the Retrieval of Interacting Genes/Proteins program (STRING
9.1) (Brohe´e and van Helden, 2006; Franceschini et al., 2013).
Each protein was thereby assigned a ‘‘combined neighborhood
score’’ relative to other proteins in the list (Table S1C). A major
cluster of 89 proteins was readily apparent within the network
whereas other annotated proteins in the network demonstrated
relatively weak clustering or no clustering at all (Figures 1C–1E;
Table S1D). Proteins within this main cluster included many
well-characterized translation factors such as eIF4A, eIF4G,
members of the eIF3 ternary complex, eIF5A, eIF5B, eIF2a,
polyadenylate binding protein 1 (PABP1), and over 50 ribosomal
proteins. We refer to this cluster as the ‘‘translation’’ cluster.
To independently analyze the list of putative BMAL1-interact-
ing proteins, we performed a Functional Annotation Clustering
Analysis using the Database for Annotation, Visualization and In-
tegrated Discovery (DAVID, v6.7) on the original list of annotated
peptides (Huang et al., 2009). This analysis demonstrated that
protein clusters involved in translation were highly represented
in the list of putative BMAL1-interacting proteins. Remarkably,
Gene Ontology and KEGG pathway analysis also nominated
translation, translational proteins, and the ribosome (Figures 1F
and S1A). Together, these data suggest that the translational
machinery is preferentially represented in proteins that co-pre-
cipitate with cytosolic BMAL1 (see also Table S1D).To confirm putative targets identified by MS, we immunopre-
cipitated endogenous BMAL1 from MEF cytosolic fractions
and immunoblotted for translation factors. We found that
BMAL1 associated with eIF4E, eIF4A, eIF4G, eIF3B, and PABP
(Figure 2A). To test for these interactions in vivo, we prepared
cytoplasmic lysates from mouse liver and brain and performed
similar immunoprecipitations with BMAL1 or control IgG.
BMAL1 co-precipitated with several translation factors in both
liver and brain (Figure 2B).
To test whether cap-binding complexes (CBCs) would asso-
ciate with BMAL1, we performed cap pull-down assays with
bead-immobilized m7-GTP, a defined method for isolating
CBC components (Sonenberg et al., 1979). BMAL1 was readily
detectable in m7-GTP pull-down assays; the addition of
competing m7-GTP nucleotide abrogated the signal suggesting
that the presence of BMAL1 on the immunoblot was specific to
interaction of BMAL1-associated complexes with the cap analog
(Figure 2C). To confirm the specificity of the BMAL1 signal, we
performed m7-GTP pull-down assays on Bmal1/ MEF lysates
and observed no BMAL1 signal (Figure 2D). We confirmed that
BMAL1 associates with the CBC in vivo by performing m7-GTP
pull-downs from liver cytoplasmic lysates (Figure 2E). Impor-
tantly, the addition of RNase to the lysates prior to pull-down as-
says did not reduce the association of BMAL1 with translation
factors in either immunoprecipitations or m7-GTP pull-down
assays, implying that BMAL1 associates with the CBC through
protein-protein interactions (Figure 2A).
We next analyzed the ribosome profile of post-nuclear cell ly-
sates and found that BMAL1 co-fractionated with translation
initiation factors (Figure 2F). This is consistent with our finding
that BMAL1 interacts with the translation initiation machinery
and points to a role for BMAL1 in translation initiation.
BMAL1 Stimulates Translation Independently of Its
Transcriptional Activity
The interaction of BMAL1 with the translation machinery raised
the question of whether BMAL1 directly affects translation. To
test this, we pulse-labeled primary Bmal1+/+ or Bmal1/ MEFs
with puromycin followed by immunoblotting with an anti-puro-
mycin antibody (i.e., SuNSET assays) (Schmidt et al., 2009).
In parallel, we also pulsed Bmal1+/+ or Bmal1/ cells with 35S-
Met/Cys as an independent measurement of de novo protein
synthesis. In both experiments, we discovered a reduction in
protein synthesis rates in Bmal1/ cells compared to WT con-
trols (Figure 2G). We conclude that BMAL1 stimulates de novo
protein synthesis in cells.
We next tested de novo protein synthesis in animals by placing
Bmal1/ or WT littermate mice in 12/12 light/dark cycles and in-
jecting themwithpuromycin intraperitoneally at eitherZT0orZT12
(Goodman et al., 2011).We found a significant decrease in protein
synthesis inBmal1/ compared to controls at ZT0 (the end of the
active period). We also noted a significant difference in protein
synthesis between ZT0 and ZT12 (the end of the rest period) in
WT mice; this difference was abrogated in Bmal1/ mice (Fig-
ure 2H). Together, these data suggest that BMAL1 promotes de
novo protein synthesis in liver during the active period.
Because BMAL1 is a transcription factor, we tested whether it
is capable of stimulating translation independently ofCell 161, 1138–1151, May 21, 2015 ª2015 Elsevier Inc. 1139
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transcription. We added a synthetic m7(G)n-capped mRNA to
cell-free rabbit reticulocyte lysates in the presence of 35S-Met/
Cys and added either recombinant GST-tagged BMAL1 to the
reaction, or GST alone as a negative control. We observed that
GST-BMAL1 significantly increased translation in a dose-depen-
dent manner whereas GST alone did not (Figure 3A). Thus,
BMAL1 can stimulate translation of cappedmRNA in a transcrip-
tion-independent system.
To directly test whether BMAL1 stimulates translation in cells
independently of its role in transcription, we engineered FLAG-
BMAL1(DbHLH), which lacks the entire basic-helix-loop helix
(bHLH) domain required for both DNA binding and transcription
(Figure 3B). We compared the translational function of FLAG-
BMAL1 and FLAG-BMAL1(DbHLH) in HEK293T cells co-trans-
fected with a bicistronic translational reporter (pYIC) in which a
constitutive CMV promoter drives a cap-dependent His-YFP in
cis with an IRES-His-CFP (Figure 3C) (Nie and Htun, 2006).
Full-length BMAL1 activated cap-dependent translation in a
dose-dependent manner (Figures 3D and 3E). Importantly, tran-
scriptionally inept FLAG-BMAL1(DbHLH) was commensurate
with WT BMAL1 at stimulating cap-dependent translation (Fig-
ures 3D–3F). Neither FLAG-BMAL1 nor FLAG-BMAL1(DbHLH)
had an effect on the transcription of pYIC, confirming that the
changes we observed in the reporter are a reflection of changes
in translation not transcription (Figure 3G). These data strongly
suggest that BMAL1 can activate translation in cells through a
mechanism that is independent of transcription.
BMAL1 Is a Substrate of S6K1
Translation regulation relies on the modulation of translational
factors by integrated signaling responses. The mTOR signaling
pathway is a crucial integrator of translational responses with
environmental and cellular cues (Ma and Blenis, 2009). In
response to anabolic stimuli, mTOR promotes translation by
phosphorylation of 4E-BPsandS6K1/2. Several S6K1 substrates
such asPDCD4, eIF4B, and eukaryotic elongation factor 2 kinase
are, in turn, translational regulators (Dorrello et al., 2006; Raught
et al., 2004; Shahbazian et al., 2006; Wang et al., 2001). S6K1 is
a member of the AGC kinase family, whose substrates have a
well-defined phosphorecognition motif (RxRxxS/T) (Pearce
et al., 2010). We observed that BMAL1 has several conserved
RxRxxS/T motifs, which led us to hypothesize that BMAL1 is an
S6K1 substrate. We performed in vitro kinase assays with acti-
vated S6K1 and observed strong transfer of 32P to GST-BMAL1
but not to GST alone (Figure 4A). To identify potential sites of
S6K1-mediated phosphorylation, we performed microcapillary-
tandemmass spectrometry (LC-MS/MS) comparing gel-purifiedFigure 1. A Screen for BMAL1 Cytosolic Interactions Nominates Trans
(A) Schematic of experimental plan for cellular fractionation, immunoprecipitation,
interact with BMAL1 in the cytosol.
(B) Representative immunoblots of WT MEF lysates separated into nuclear and c
(C) BMAL1 Cytosolic Interaction Network demonstrates a single major cluster.
(D) The largest and most connected cluster in the network is the ‘‘Translation’’ C
translation factors. See also Table S1 and Figure S1.
(E) List of a subset of translation factors identified by LC-MS/MS found in the ‘‘T
(F) The list of annotated putative co-precipitating proteins was loaded into the DA
was ‘‘Ribosome.’’GST-BMAL1 that had been subjected to kinase assays either
with or without the addition of recombinant S6K1 (Bordoli et al.,
2014; Breitkopf and Asara, 2012). LC-MS/MS analyses detected
phosphorylation at S42, a serine situated within a canonical
RxRxxS/T (37-RKRKGS-42) motif and evolutionarily conserved
across phyla suggesting that it is functionally important (Fig-
ure 4B). To confirm that S42 was an S6K1 site, we repeated
kinase assays with WT FLAG-BMAL1 or a phosphorylation-
incompetent mutant FLAG-BMAL1(S42G). While 32P was readily
incorporated into FLAG-BMAL1, almost none was detected in
FLAG-BMAL1(S42G) (Figure 4C). These data demonstrate that
S42 is a primary site of S6K1-mediated phosphorylation in vitro.
Using a phospho-specific BMAL1(S42) antibody, we tested
whether BMAL1 is phosphorylated at S42 in cells. We confirmed
phospho-specificity of the antibody with in vitro kinase assays
(Figure S1B). We then produced four immortalized, stably trans-
duced MEF lines: Bmal1+/+:GFP, Bmal1/:GFP, Bmal1/:B-
MAL1 (re-expressing WT BMAL1), and Bmal1/:BMAL1(S42G)
(re-expressing phosphorylation-incompetent BMAL1). Anti-
phospho-BMAL1(S42) antibody yielded a signal in bothBmal1+/+:
GFP and Bmal1/:BMAL1 cells but in neither Bmal1/:GFP nor
Bmal1/:BMAL1(S42G) cells. These data confirm that BMAL1 is
phosphorylated at S42 in cells (Figure 4D).
To test whether S42 is a substrate of S6K in vivo, we probed
for BMAL1 phosphorylation at S42 in S6K1/;S6K2/ (DKO)
MEFs and WT MEFs. While WT cells demonstrated a strong
phospho-BMAL1(S42) signal, we detected little phosphorylation
in DKO cells (Figure 4E). We further confirmed that BMAL1 is a
direct substrate of the mTOR pathway, by testing small hairpin
RNA (shRNA)-mediated knockdown of the mTORC1-specific
component raptor (Laplante and Sabatini, 2012). We observed
a marked decrease in phospho-BMAL1(S42) in sh-raptor cells
compared to controls (Figure 4F). The TSC1 and TSC2 tumor
suppressors inhibit mTORC1 activation; thus, deletion of either
protein results in a state of growth factor-independent mTORC1
activation. We observed increased phospho-BMAL1(S42) in hip-
pocampal lysates of mice harboring neuron-specific deletion of
Tsc1 compared to those of control littermates (Figures 4G and
4H). Together, these data further support the conclusion that
BMAL1 is a S6K substrate downstream of mTORC1.
Phosphorylation at S42 Is Required for BMAL1 to
Promote Translation
Phosphorylation regulates the activity of several translation
factors (Sonenberg and Hinnebusch, 2009). We found that
phosphorylated BMAL1 co-fractionated with translation initia-
tion factors at the ribosome (Figure S1C). To directly test whetherlation
and tandemmass spectrometry (LC-MS/MS) to isolate proteins that putatively
ytosolic fractions probed with indicated antibodies.
luster, comprised of 89 proteins including over 50 ribosomal proteins and 15
ranslation’’ Cluster.
VID algorithm. The only significantly nominated pathway from KEGG analysis
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Figure 2. BMAL1 Associates with Translation Initiation Factors and Stimulates Translation in Cells
(A) Representative western blot of unsynchronized WT MEFs. Cells were fractionated and immunoprecipitations performed with anti-BMAL1 monoclonal
antibody or mouse IgG.
(B) BMAL1 associates with translation factors in vivo. Cytoplasmic extract from mouse liver or brain were immunoprecipitated with anti-BMAL1 monoclonal
antibody or mouse IgG. Western blots were performed with indicated antibodies.
(legend continued on next page)
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phosphorylation at S42 is required for BMAL1’s association
with translation factors, we transfected HEK293T cells with
FLAG-BMAL1 or FLAG-BMAL1(S42G), immunoprecipitated
with anti-FLAG antibody, and probed immunoprecipitates for
CBC proteins. WT BMAL1 strongly associated with eIF4E,
eIF4A, eIF4G, and eIF2a. In contrast, BMAL1(S42G) did not (Fig-
ure 5A). We performed m7-GTP pull-down assays on similarly
transfected cells. Again, WT BMAL1 strongly associated with
translation factors in CBC pull-downs whereas BMAL1(S42G)
did not (Figure 5B). We conclude that S42 phosphorylation is
required for BMAL1 to interact with the CBC.
We hypothesized that if S42 phosphorylation is required
for CBC association, then BMAL1(S42G) would be less efficient
at promoting translation when compared to WT BMAL1. We
performed bicistronic reporter assays comparing BMAL1 to
BMAL1(S42G) (as in Figure 3) and found that, even at highest
expression levels, BMAL1(S42G) did not promote cap-dependent
translation (Figures5Cand5D).Weconfirmed thisfindingusingan
independent bicistronic translational reporter (Figure S2).
Phosphorylation at other BMAL1 serine residues has been
previously shown to affect BMAL1 stability and nuclear entry
(Sahar et al., 2010). We noted that the S42 site (37-RKRKGS-42)
is directly adjacent to 38-KR-39 residues previously identified as
a nuclear localization signal for BMAL1 (Kwon et al., 2006).
Thus, we considered the possibility that BMAL1-S42G might
neither interact with the CBC nor activate translation because
of changes in its stability or subcellular localization. However,
several findings make this unlikely. First, the S42G mutant was
more stable than WT BMAL1 (Figures S3A and S3B). Second,
we found that more BMAL1-S42G localized to the cytoplasm
in MEFs compared to WT BMAL1 (Figure S3C). This effect may
be secondary to S6K1-mediated phosphorylation as either WT
BMAL1 expressed in S6K1/ cells or BMAL1(S42G) expressed
in S6K1+/+ cells demonstrated indistinguishable BMAL1 subcel-
lular localization (Figure S3C). These data make it unlikely that
changes in BMAL1(42G) stability or subcellular localization could
explain the inability of the phosphorylation-incompetent protein
to interact with the translational machinery. Thus, we conclude
that BMAL1 phosphorylation at S42 is required for BMAL1 to
promote translation by regulating its interaction with the transla-
tion machinery.
High levels of S6K1 expression have been recurrently impli-
cated in breast cancer leading us to examine a role for(C) Cytoplasmic MEF lysates were prepared as in (A) and incubated with m7-GTP
as indicated. m7-GTP (1 mM) was used as a cap competitor.
(D) BMAL1 m7-GTP pull-down is specific. Bmal1+/+ or Bmal1/ MEF lysates we
(E) BMAL1 associates with CBCs in vivo. Cytoplasmic extracts of mouse liver (a
beads. Western blots were performed with indicated antibodies.
(F) An extract of Bmal1+/+:GFP MEFs was subjected to sucrose density gradient
fractionated; fractions were analyzed by western blotting. Note that BMAL1 and
identifies the small ribosomal subunit.
(G) Primary MEFs (passage 2–4) of indicated genotype were pulsed with 1 mMpuro
mean ratio of puromycin to total protein (Coomassie) ± SEM normalized to WT (n
per genotype were used. The same cell lines were pulsed with 35S-Met/Cys f
determined as the mean ratio of 35S incorporation relative to total protein (Coom
(H) BMAL1 regulates protein synthesis in the liver. Puromycin was injected 30 mi
light/dark cycle. Livers were harvested and whole cell lysates prepared. Protein s
SEM is shown for the indicated number of mice (p = 0.01 for interaction, ***p < 0BMAL1-mediated translation in breast cancer cells (Couch
et al., 1999; Maruani et al., 2012). We observed that BMAL1(S42)
phosphorylation was detectable at high levels in MCF7 cells, in
which S6K is active even in low-serum conditions (Figure S4A).
Treatment of MCF7 with rapamycin reduced BMAL1 phosphor-
ylation and de novo protein synthesis (Figure S4A). Importantly,
overexpression of phosphorylation-competent BMAL1 in MCF7
cells increased the number of metabolically active cells while the
phosphorylation-incompetent BMAL1(S42G) had no significant
effect (Figure S4B). The effect of BMAL1 on proliferation was
dependent on the presence of serum. Together, these data
suggest a role for BMAL1 phosphorylation in the promotion of
translation and proliferation in breast cancer cells.
To further examine the mTORC1-dependence of BMAL1
phosphorylation in vivo, we tested brain-specific Tsc1 knock-
outs treated with vehicle or rapamycin. Consistent with our pre-
vious data, we noted a marked increase in BMAL1 phosphoryla-
tion in Tsc1 mutant hippocampus (Figure 5E). Rapamycin
resulted in a decrease in phospho-S6K1 and a decrease in phos-
pho-BMAL1 as well as a decrease in the association of BMAL1
with the m7-GTP cap (Figures 5E and 5F). These data substanti-
ate that S6K1-mediated BMAL1 phosphorylation promotes as-
sociation of BMAL1 with the translational machinery in vivo.
BMAL1 Rhythmically Associates with the Translational
Machinery
BMAL1 has been previously reported to shuttle between the
cytosol and nucleus with a circadian oscillation (Kwon et al.,
2006; Tamaru et al., 2003). We asked whether the interaction
of BMAL1 with the translational machinery varies during the
circadian cycle. We synchronized MEFs with 100 nM dexameth-
asone and performed subcellular fractionation followed by
biochemical assays (Figures 6 and S5A). Levels of cytosolic
BMAL1 initially decreased from zeitgeber time (ZT) (i.e., time
post-synchronization) 16–24 hr after synchronization and then
increased thereafter (Figure 6A). We confirmed this circadian
variability by immunocytochemistry, which demonstrated that
the cytoplasmic BMAL1 staining was markedly increased at
ZT36 compared to ZT24 (Figures S5B and S5C).
We next immunoprecipitated BMAL1 from the cytosol at
different ZTs (Figure 6B). BMAL1 rhythmically associated with
S6K1, eIF4E, eIF4A, PABP, and eIF3B in a pattern that followed
its phosphorylation at S42. Starting at ZT16 the level of-agarose beads. Co-eluting proteins were resolved by SDS-PAGE, and probed
re prepared as in (A).
s in B) were normalized to total protein and incubated with m7-GTP-agarose
centrifugation. The absorbance profile at 260 nm is shown. The gradient was
eIF4E were found in the same ribosomal fractions. Ribosomal protein (rpS6)
mycin for 30min, and de novo protein synthesis was quantified by detection of
= 7, **p = 0.002, Student’s t test). Independent cell lines from at least two mice
or 30 min followed by lysis and SDS-PAGE. De novo protein synthesis was
assie) ± SEM (n = 3, *p = 0.04, Student’s t test).
n before indicated time points intoWT or Bmal1/ mice kept on a 12 hr/12 hr
ynthesis was calculated as the ratio of puromycin/total protein, and the mean ±
.0001 for genotype, *p < 0.02 for time, two-way ANOVA, Tukey post test).
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Figure 3. BMAL1 Can Stimulate Translation Independent of Its Role in Transcription
(A) Recombinant full-length human GST-tagged BMAL1 stimulates translation in vitro in rabbit reticulocyte lysates. Synthetic m7-GTP capped Xef1 mRNA was
added to each reaction with increasing amounts of GST-BMAL1 incubated with 35S-Met/Cys. Lysates were resolved by SDS-PAGE, autoradiography performed,
and western blots were probed as indicated. Quantification of de novo protein synthesis was performed by calculating the mean volume of 35S compared to
control ± SEM (**p = 0.005, *p < 0.05, one-way ANOVA with Tukey post test, n = 3 replicates).
(B) Cartoon of CMV-FLAG-BMAL1 plasmids. CMV-FLAG-BMAL1(DbHLH) yields a predicted protein product 15 kDa smaller than WT.
(C) Cartoon of the pYIC bicistronic translational reporter plasmid (Nie and Htun, 2006). His, 6xHis tag.
(D) Representative western blot of HEK293T cells transfected with pYIC and indicated amounts of FLAG-BMAL1 or FLAG-BMAL1(DbHLH) and/or empty vector
(pcDNA3.1). Total DNA, 1.8 mg/condition.
(legend continued on next page)
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association decreased until ZT28 and then, as both total and
phosphorylated levels of BMAL1 increased, association with
translation factors also increased.
BMAL1 and phospho-BMAL1(S42) associated with the cap
analog m7-GTP in pull-down assays at ZT16-20 and then the
association declined precipitously to nearly undetectable levels
(Figure 6C). Importantly, we did not observe BMAL1 or phos-
pho-BMAL1(S42) associate with the cap analog at 36 hr after
synchronization. One interpretation of these findings is that
BMAL1 associates with the translational machinery prior to the
assembly of the translational initiation complexes with the
mRNA cap.
Previous studies have demonstrated oscillations in the mTOR
pathway in mouse liver with peak phospho-S6 levels at the start
of the subjective night (the dark period) (Cornu et al., 2014; Jouffe
et al., 2013; Khapre et al., 2014). Consistent with these studies,
we observed maximal phospho-S6 levels during the active
period with a clear variation between circadian night and day.
We queried phospho-BMAL1(S42) during the circadian cycle in
cytoplasmic extracts from mouse liver harvested in constant
darkness. We observed that phosphorylation peaked at the
end of the active period (Figure 6D). Similarly, we observed
that in m7-GTP pull-down assays from the same lysates that
BMAL1 maximally associated with cap binding complexes dur-
ing the active period (Figure 6E). These data are consistent
with our previous finding that de novo protein synthesis is rela-
tively high in the liver at the end of the active period (Figure 2H).
Together these data suggest that BMAL1 undergoes circadian
phosphorylation by S6K1 during the circadian cycle in phase
with its association with the translational machinery in vivo.
Protein Synthesis Rates Demonstrate Circadian
Rhythmicity
The rhythmicity of BMAL1 association with the translational ma-
chinery and its ability to promote translation led us to investigate
whether synchronized cells demonstrate circadian rhythms of
overall protein synthesis rates. Rhythms of both protein synthe-
sis in the SCN and polysome quantity in the liver have been re-
ported (Jouffe et al., 2013; Shibata et al., 1992). We tested this
question in U2-OS cells stably expressing a Per2:Luciferase
transgene (PLuc cells) (Zhang et al., 2009). PLuc cells demon-
strated strong circadian rhythms in protein synthesis rate (Fig-
ure S6). The observed rhythm is unlikely an artifact of culturing
conditions because they persist for 2 days after synchronization,
suggesting the involvement of a clock mechanism.
BMAL1 is essential to circadian rhythms in transcription
(Bunger et al., 2000). Other groups have demonstrated that the
rhythmic expression of ribosomal subunits (with non-rhythmic
mRNAs) in the liver is altered in Bmal1/ mice (Jouffe et al.,
2013). Thus, we asked whether BMAL1 plays a role in circadian(E) Histograms of data from (D). Cap-dependent YFP signal was normalized to ac
plasmid (*p < 0.05; **p < 0.01, amount of BMAL1 plasmid; WT versus DbHLH, no
(F) BMAL1(DbHLH) did not significantly activate the BMAL1 transcriptional targe
BMAL1 co-activator myc-CLOCK. Data are represented as the mean ± SEM of Re
test; BMAL1(DbHLH), not significant).
(G) BMAL1 overexpression has no effect on pYIC transcription in HEK293T cells.
not significant, Tukey post test, n = 3 replicates).protein synthesis rates using the four immortalized cell lines uti-
lized in Figure 4D. We pulsed cells with 35S-met/cys every 4 hr
after synchronization tomeasure protein synthesis rates (Figures
7A–7H and S7A–S7D). Bmal1+/+:GFP cells demonstrated a clear
circadian oscillation in 35S-met/cys incorporation over 2 days
after synchronization with high levels from 16–24 and 40–48 hr
after synchronization and relatively low levels from 28–36 and
52–60 hr after synchronization (Figures 7A, 7E, and S7E). Impor-
tantly, this pattern of de novo protein synthesis correlated
well with the association of BMAL1 with the cap complex at
16–20 hr after synchronization (Figure 6C). The observed
rhythms persisted for 2 days, suggesting the involvement of an
autonomous timing mechanism.
Although a circadian oscillation in protein synthesis was
partially preserved in Bmal1/:GFP cells, the peak protein syn-
thesis levels during the ‘‘positive limb’’ of the cycle was dimin-
ished and overall amplitude reduced (Figures 7B, 7F, S7E, and
S7F). Surprisingly, Bmal1/:BMAL1 cells, which overexpress
WT BMAL1, also demonstrated a similar reduction in amplitude
of the protein synthesis oscillation over the circadian cycle
(Figures 7C, 7G, S7E, and S7F). In contrast, overexpression of
BMAL1 in neither PLuc cells nor Bmal1/ MEFs abolished
transcriptional rhythms of Per2:Luc; furthermore, Per2:Luc oscil-
lations did not differ in Bmal1/ cells overexpressing either WT
BMAL1 or BMAL1(S42G) (Figures S7G and S7H). These findings
are consistent with previous reports that have shown that circa-
dian transcriptional rhythms are not lost with BMAL1 overex-
pression, presumably because of the preservation of negative
feedback mechanisms that tolerate high BMAL1 protein levels
(Kiyohara et al., 2006). Thus, the diminution of protein synthesis
rhythms in Bmal1/:BMAL1 cells imply first that, in contrast to
circadian transcriptional oscillations, the level of BMAL1 protein
expression is critical to the expression of circadian rhythms
of protein synthesis; second, that rhythms of protein synthesis
oscillations and specifically, putative negative feedback
mechanisms controlling them, are likely distinct from those
involved in negative feedback of circadian transcription. Finally,
Bmal1/:BMAL1(S42G) cells, which overexpress a phospho-
incompetent form of BMAL1, demonstrated diminished protein
synthesis rates and circadian rhythmicity similar to that of
Bmal1/:GFP cells (Figures 7D, 7H, 7I, and S7D–S7F). These
results are consistent with our previous findings that BMAL1
phosphorylation at S42 regulates BMAL1’s ability to stimulate
translation.
DISCUSSION
In this study, we show that BMAL1 is a translation factor, which in
response to phosphorylation by S6K1, regulates rhythms of pro-
tein synthesis (Figure 7I). Shuttling of circadian clock proteinstin by densitometry. Mean intensity ± SEM are shown normalized to no BMAL1
t significant; two-way ANOVA, n = 4–6 per condition).
t Rev-Erba. HEK293T cells were transfected as in (D) with the addition of the
v-Erba RNA normalized to control (***p < 0.0001, one-way ANOVA, Tukey post
Data are represented as the mean of YFP(pYIC) RNA ± SEM (one-way ANOVA
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Figure 4. BMAL1 Is Phosphorylated by S6K1 In Vitro and In Vivo
(A) Recombinant full-length GST-BMAL1 was incubated with His-S6K1 and 32P-gATP. Reactions were resolved by SDS-PAGE, and autoradiography was
performed followed by western blotting. Arrows indicate GST monomers (solid) or GST dimers (dashed).
(B) Outline of workflow for LC-MS/MS experiments to identify sites of S6K1-mediated BMAL1 phosphorylation. Dark blue rectangles approximate the relative
representation of BMAL1 peptides in the LC-MS/MS data. Below, alignment of the putative S6K1 phosphorylation site at S42 (in human BMAL1) demonstrates
evolutionary conservation across phyla.
(C) S42 is an S6K1 phosphorylation site in vitro. HEK293T cells were transfected with either FLAG-BMAL1 or FLAG-BMAL1(S42G). FLAG immunoprecipitations
were performed and washed. Recombinant S6K1 was added in the presence of 32P-gATP. Autoradiography was performed followed by western blotting.
(D) BMAL1 is phosphorylated at S42 in vivo.Western blot of lysates from immortalized Bmal1 cell lines as indicated. Overexpressed BMAL1 is detected at higher
level and is larger in size because of FLAG-HA tag.
(E) S6Ks phosphorylate BMAL1 in cells. Whole cell lysates from WT or S6K1/2 double knockout (DKO) cells were probed with indicated antibodies.
(F) BMAL1 is phosphorylated at S42 downstream of mTORC1. WT MEFs were infected with lentivirus expressing a scrambled shRNA (control) or sh-raptor.
(G and H) Hippocampal lysates from SynapsinI-Cre;Tsc1-flox/flox (KO) or SynapsinI-Cre;Tsc1+/+ (control) mice were probed with indicated antibodies. Histogram
of quantified western blots from (G). Data are represented as the mean ± SEM relative to WT (n = 3 mice per genotype, t test, *p < 0.05, **p < 0.005).
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Figure 5. BMAL1 Phosphorylation at S42 Mediates Its Interaction with Translational Machinery and Promotes Cap-Dependent Translation
(A) HEK293T cells were transfected with FLAG-BMAL1 or FLAG-BMAL1(S42G). 24 hr later, cells were lysed and immunoprecipitated with FLAG antibody.
Western blots were probed with indicated antibodies.
(B) HEK293T cells were transfected with 10 mg or 20 mg of FLAG-BMAL1 or FLAG-BMAL(S42G) for 24 hr. Post-nuclear cell fractions were treated with RNase A
followed by m7-GTP pull-down assays. Western blots were probed as indicated.
(C) HEK293T cells were transfected with pYIC and FLAG-BMAL1 or FLAG-BMAL1(S42G) as in Figure 3D. Cell lysates were probed with indicated antibodies. See
also Figures S2, S3, and S4.
(D) Quantification of data from (C). His-YFP (cap-dependent) was normalized to actin and the mean ± SEM is represented normalized to control. **p < 0.01,
BMAL1 plasmid for WT and non-significant (ns) for S42G. **p < 0.01, WT versus S42G (two-way ANOVA) n = 4– replicates per condition.
(legend continued on next page)
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Figure 6. BMAL1 Rhythmically Associates
with S6K1 and the Translational Machinery
(A) WT MEFs were synchronized with dexameth-
asone followed by subcellular fractionation over a
sucrose cushion at indicated time points. Repre-
sentative western blot is shown (n = 4 biological
replicates; see Figure S5 for nuclear lysates).
(B and C) BMAL1 immunoprecipitation of normal-
ized cytosolic lysates were treated with RNase and
subjected to immunoprecipitation with BMAL1
antibody (B) or pull-down assays with m7-GTP
beads (C). Western blots were performed with
indicated antibodies. Asterisk corresponds to the
IgG-heavy chain and small arrow to IgG-light
chain, respectively (see Figure S5).
(D) BMAL1 phosphorylation rises during the active
period in liver. Mice were maintained on a 12 hr/
12 hr light/dark schedule with ad libitum availability
to food prior to release into constant darkness.
Tissues were collected at indicated time
points. Liver cytoplasmic extracts were collected,
normalized to total protein, and immunoblots were
performed. Representative western blot from n = 3
mice per time point is shown.
(E) Extracts prepared from (D) were normalized to
total protein content, and subjected to m7-GTP
pull-down assays followed by immunoblotting as
indicated.between the nucleus and cytoplasm has been known for years;
however, biological functions for circadian clock proteins in the
cytoplasm have not been widely examined. Our unbiased screen
for proteins that interact with BMAL1 in the cytosol identified
hundreds of proteins, and those involved in translation and
mRNA processing were the most highly represented (Figures 1
and S1A; Tables S1A–S1D). S6K1-mediated BMAL1 phosphor-
ylation at S42 is required for BMAL1 to both interact with the
translational machinery and stimulate protein synthesis, placing
BMAL1 in context of other S6K1 substrates involved in transla-
tion (Dorrello et al., 2006; Raught et al., 2004; Shahbazian
et al., 2006). These findings provide a direct molecular link
between BMAL1 and the mTOR pathway.
Consistent with others, we have found that themTOR pathway
demonstrates circadian rhythmicity in both synchronized cells
and mouse liver. Phospho-S6 levels rise and fall with the circa-(E) Western blots of hippocampal lysates of SynapsinI-Cre;Tsc1+/+ (Tsc1-Control) or SynapsinI-Cre;Tsc1-flo
Data are represented as the mean ± SEM relative to WT (n = 2 mice per genotype per condition, one-way A
(F) m7-GTP pull-down assays were performed on pooled cytoplasmic lysates from (E) and immunoblots
antibodies.
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in mouse liver (Cornu et al., 2014; Jouffe
et al., 2013). Similarly, we see levels of
phospho-BMAL1 peak in the circadian
night and diminish during mid-day. This
parallels an increase in BMAL1 associa-
tion with the mRNA cap during the circa-
dian night and fits well with a relative in-
crease in protein synthesis during theactive period (see Figures 2H, 6B, 6C, and 6E). Interestingly,
BMAL1 transcriptional activity peaks during the mid-late morn-
ing (Koike et al., 2012), suggesting a subcellular segregation of
BMAL1 function during the circadian cycle. Thus, phosphoryla-
tion of BMAL1 during the circadian cycle by rhythmic activity
of S6K1 is a potential mechanism by which temporal variation
is conveyed to the translational machinery on circadian time-
scales (Figure 7I).
Several studies have argued that transcriptional rhythmicity is
not always predictive of rhythmic protein expression (Mauvoisin
et al., 2014; Reddy et al., 2006). Thus, circadian transcription is
likely not the sole provenance of circadian information in cells
(O’Neill and Reddy, 2011). Indeed, inhibiting transcription within
four hours of a puromycin pulse did not eliminate rhythms in de
novo protein synthesis in synchronized cells (Figure S6C). It is
axiomatic that translation is fundamentally dependent onx/flox (Tsc1-KO) treated with vehicle or rapamycin.
NOVA, Tukey post test, *p < 0.05).
of eluted proteins were performed with indicated
A B C D
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Figure 7. Circadian Rhythms of Protein Synthesis Rates Are Partially BMAL1 and Phospho-BMAL1(S42) Dependent
(A–D) Bmal1+/+:GFP MEFs were synchronized with dexamethasone. At indicated time points, cells were pulsed with 35S-Met/Cys every 4 hr from hours 16–60
after synchronization followed by cell lysis, SDS-PAGE, autoradiography, and western blotting (below). Representative autoradiograms of the same exposure
were pseudocolored for visual clarity (see Figures S7A–S7D for originals), n = 3 replicates per cell line. See also Figures S6 and S7.
(E–H) Quantification of (A)–(D). 35S autoradiograms were quantified by densitometry, normalized to Coomassie-stained gels for total protein and normalized to
Bmal1+/+:GFP cells at ZT16.
(I) Schematic model of BMAL1 phosphorylation and association with the translational machinery in the cytosol during the circadian cycle.transcription; however, systems-level analysis of protein expres-
sion suggests that protein copy number is more dependent on
translation rate than mRNA copy number (Schwanha¨usser
et al., 2011). This points to the pivotal importance of translationalcontrol mechanisms at initiation and at the ribosome in the regu-
lation of protein expression (Sonenberg and Hinnebusch, 2009).
The question of circadian rhythms in protein synthesis is not new.
While contested, circadian rhythms of protein synthesis haveCell 161, 1138–1151, May 21, 2015 ª2015 Elsevier Inc. 1149
been demonstrated in both the SCNand inDrosophila clock neu-
rons (Huang et al., 2013; Scammell et al., 1989; Shibata et al.,
1992). Several recent studies have demonstrated a role for
translational control of clock proteins (Cao et al., 2013; Lim
and Allada, 2013a; Lim et al., 2011). Our study did not assess
BMAL1’s translational function in the core circadian oscillator.
Studies of human erythrocytes and the algaO. tauri have demon-
strated a conserved post-translational circadian clock that is
transcription-independent (O’Neill and Reddy, 2011; O’Neill
et al., 2011). We have found that BMAL1’s ability to stimulate
translation is independent of its transcriptional function, while
S6K1-mediated phosphorylation is essential for BMAL1 to
interact with the translational machinery. Thesemolecular details
could allow the dissection of the relative transcriptional and
translational contributions BMAL1 makes to both the control
of circadian timing and pathological states such as cancer,
metabolic disease, neurological disease, and aging (Cornu
et al., 2013; Lipton and Sahin, 2014; Zoncu et al., 2011).
EXPERIMENTAL PROCEDURES
All animal work was performed according to protocols approved and super-
vised by the Animal Care Facility of Boston Children’s Hospital. Please see
Supplemental Experimental Procedures for detailed protocols.
Mass Spectrometry on Cytosolic Fractions
All steps were performed on ice or at 4C, unless otherwise specified. Cyto-
plasmic fractions from immortalized WT MEFs were isolated and normalized.
Total protein (6 mg) was pre-cleared with 10 ml of pre-washed (23 with PBS
and once with lysis buffer [Buffer 1]) DynaBeads Protein G (Invitrogen) and
gently agitated for 15 min. Non-immobilized fractions were retrieved using a
magnetic separation rack (NEB) and placed in fresh pre-chilled 1.5-ml tube.
Immunoprecipitations were performed by adding 3 mg of BMAL1 monoclonal
antibody (Santa Cruz #365645)/mg total protein and incubated overnight with
gentle end-over-end agitation; ‘‘mock’’ reactions were treated identically,
however, no primary antibody was added to the lysate. 16 hr later, 40 ml of
fresh, pre-washed Protein G beads were added to each reaction for 1 hr
with gentle agitation. Reactions were then placed on magnetic rack separator
and beads were washed with Buffer 1 four times. After the final wash, 1 vol of
23 Laemmli sample buffer with b-mercaptoethanol was added to each reac-
tion and boiled at 95C for 5min, then placed on ice. The eluates were retrieved
on a magnetic rack and placed in a fresh tube. Proteins were separated by
SDS-PAGE on 4%–20% gradient gels (Bio-Rad) and stained with Coomassie
Blue for 15–20 min followed by de-staining at room temperature for 1 hr. Entire
lanes were cut into pieces, washed twice with 50% mass spectrometry grade
acetonitrile (Thermo Scientific) followed by two washes with high purity water.
Gel slices were submitted for trypsinization and mass spectrometric analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2015.04.002.
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